Barinthus Biotherapeutics plc. — Director's Dealing 2021

Apr 30, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vaccitech plc (VACC)
CIK: 0001828185
Period of Report: 2021-04-29

Reporting Person: Egorov Georgy (Chief Financial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Share Option (Right to Buy)	$0.0004	2030-10-30	Ordinary Shares (176130)		Direct

Footnotes

F1: This option shall vest and become exercisable as follows: 25% vested on October 19, 2020, 25% shall vest upon the successful completion of the Issuer's initial public offering, 25% shall vest on October 19, 2021 and 25% shall vest on October 19, 2022. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3662 to GBP 1.00 on December 31, 2020.

F2: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.